神经干细胞与胶质瘤干细胞的静息调控共享分子机制并揭示治疗脆弱点
Shared molecular regulation of quiescence in neural and glioma stem cells reveals therapeutic vulnerabilities

Choudhury 等构建了 48 个基因的静息特征评分(QSig),显示静息胶质瘤细胞与成体神经干细胞共享一条保守的激活轨迹,并识别出能在药理学上促进胶质瘤细胞静息的化合物类别。该研究发表于 Stem Cell Reports,摘要未给出样本量、具体化合物名称及实验体系细节。
原文摘要
出版方登记 · CrossrefQuiescence, a reversible state of cell-cycle arrest, is an adaptive feature of many adult tissue stem cells, including those in the adult brain. In gliomas, brain tumour stem cells that reside in a quiescent state preferentially survive chemotherapy and radiotherapy, highlighting their critical role in therapy resistance and disease progression. To date, it remains unclear whether the molecular programs governing these states are functionally conserved between neural stem cells and brain tumour stem cells. Here, we establish novel in vitro models to study quiescence and find that glioma stem cells are markedly more resistant to entering quiescence than neural stem cells, suggesting that glioma stem cell quiescence more closely resembles a slow-cycling phenotype or shallow quiescence. Nonetheless, direct comparison of quiescent neural stem cells and quiescent/slow-cycling glioma stem cells, as they transition towards proliferation, reveals conserved gene expression trajectories, indicating shared molecular mechanisms. Furthermore, we find that pathways influencing quiescence in neural stem cells exert similar effects in glioma stem cells, underscoring the functional parallels between these populations. Finally, we identify that inhibition of TGF-β signalling might provide an avenue to improve current standard-of-care treatments by targeting quiescent glioma stem cells. Note on version 2 This version corrects two figure errors and expands the Methods. The conclusions of are unchanged. Images In version 1, debris adjacent to the organoid had been digitally removed from the drug-treated image in Figure 6D. The unmodified original is restored here. Images within Figures 3A and 6D have each been processed identically to one another. Scattered cellular debris was present to a similar extent in control and drug-treated samples. Data The glioblastoma organoid data in Figure 6E have been updated following re-imaging and blinded re-analysis. Reported effect sizes have changed slightly; the conclusions are unchanged. Figure S2 has likewise been updated following re-imaging and re-analysis. Methods The Methods have been expanded to describe the analysis more fully, including data exclusion criteria, normalisation, and blinding. Minor changes to figure legends and the main text are not itemised.
页面未能读取全文,以上为出版方登记的摘要;方法与图表见原文
来源:Stem Cell Reports · cell.com